Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 Exhibit 5.1
- 8.1 Exhibit 8.1
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 23.1 Exhibit 23.1
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- EX-FILING FEES Ex-filing Fees
- Download Excel data file
- View Excel data file
Associated filings
- 26 Jun 24 EFFECT Notice of effectiveness
- 25 Jun 24 424B3 Prospectus supplement
-
24 May 24 S-4 Registration of securities issued in business combination transactions
TLSI similar filings
- 24 May 24 Registration of securities issued in business combination transactions
- 14 Jul 23 Registration of securities issued in business combination transactions (amended)
- 11 Jul 23 Registration of securities issued in business combination transactions (amended)
- 6 Jul 23 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 11, 2024, with respect to the consolidated financial statements of TriSalus Life Sciences, Inc., included herein, and to the reference to our firm under the heading "Experts" in the prospectus.
/s/ KPMG LLP
Denver, Colorado
May 23, 2024